| Maria Elena Rodriguez, MD | |
|
5626 Curry Ford Rd, Orlando, FL 32822 | |
| (407) 985-5677 | |
| (844) 388-6186 |
| Full Name | Maria Elena Rodriguez |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 36 Years |
| Location | 5626 Curry Ford Rd, Orlando, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023132578 | NPI | - | NPPES |
| 016832600 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | ME100303 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Primary Healthcare Associates, Inc | 4183606601 | 19 |
News Archive
Remember when Grandma used to say, "don't go out in the cold; you'll get sick"? It turns out that she was right for a small number of people who have a condition called familial cold autoinflammatory syndrome (FCAS)
A new theory that explains why the language of our genes is more complex than it needs to be also suggests that the primordial soup where life began on earth was hot and not cold, as many scientists believe.
As the coronavirus disease (COVID-19) pandemic continues to spread and wreak havoc globally, another health threat emerged in China. The country has reported its first confirmed case of the rare H10N3 bird flu in a patient admitted to the hospital in April 2021 in Zhenjiang, China.
Pfizer Inc. announced today that the European Commission has granted conditional marketing authorization for BOSULIF (bosutinib) in the European Union for the treatment of adult patients with chronic phase, accelerated phase and blast phase Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, and Intellikine, Inc., a leader in the development of small molecule drugs targeting the PI3K/mTOR pathway, today announced an agreement under which Infinity obtained global development and commercialization rights to Intellikine's portfolio of inhibitors of the delta and gamma isoforms of phosphoinositide-3-kinase.
› Verified 5 days ago
| Entity Name | Primary Healthcare Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063544963 PECOS PAC ID: 4183606601 Enrollment ID: O20040607000910 |
News Archive
Remember when Grandma used to say, "don't go out in the cold; you'll get sick"? It turns out that she was right for a small number of people who have a condition called familial cold autoinflammatory syndrome (FCAS)
A new theory that explains why the language of our genes is more complex than it needs to be also suggests that the primordial soup where life began on earth was hot and not cold, as many scientists believe.
As the coronavirus disease (COVID-19) pandemic continues to spread and wreak havoc globally, another health threat emerged in China. The country has reported its first confirmed case of the rare H10N3 bird flu in a patient admitted to the hospital in April 2021 in Zhenjiang, China.
Pfizer Inc. announced today that the European Commission has granted conditional marketing authorization for BOSULIF (bosutinib) in the European Union for the treatment of adult patients with chronic phase, accelerated phase and blast phase Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, and Intellikine, Inc., a leader in the development of small molecule drugs targeting the PI3K/mTOR pathway, today announced an agreement under which Infinity obtained global development and commercialization rights to Intellikine's portfolio of inhibitors of the delta and gamma isoforms of phosphoinositide-3-kinase.
› Verified 5 days ago
| Entity Name | Guidewell Sanitas I, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396124046 PECOS PAC ID: 9537447107 Enrollment ID: O20161102001073 |
News Archive
Remember when Grandma used to say, "don't go out in the cold; you'll get sick"? It turns out that she was right for a small number of people who have a condition called familial cold autoinflammatory syndrome (FCAS)
A new theory that explains why the language of our genes is more complex than it needs to be also suggests that the primordial soup where life began on earth was hot and not cold, as many scientists believe.
As the coronavirus disease (COVID-19) pandemic continues to spread and wreak havoc globally, another health threat emerged in China. The country has reported its first confirmed case of the rare H10N3 bird flu in a patient admitted to the hospital in April 2021 in Zhenjiang, China.
Pfizer Inc. announced today that the European Commission has granted conditional marketing authorization for BOSULIF (bosutinib) in the European Union for the treatment of adult patients with chronic phase, accelerated phase and blast phase Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, and Intellikine, Inc., a leader in the development of small molecule drugs targeting the PI3K/mTOR pathway, today announced an agreement under which Infinity obtained global development and commercialization rights to Intellikine's portfolio of inhibitors of the delta and gamma isoforms of phosphoinositide-3-kinase.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Maria Elena Rodriguez, MD 308 W Bass St, Kissimmee, FL 34741-5001 Ph: (407) 483-8801 | Maria Elena Rodriguez, MD 5626 Curry Ford Rd, Orlando, FL 32822 Ph: (407) 985-5677 |
News Archive
Remember when Grandma used to say, "don't go out in the cold; you'll get sick"? It turns out that she was right for a small number of people who have a condition called familial cold autoinflammatory syndrome (FCAS)
A new theory that explains why the language of our genes is more complex than it needs to be also suggests that the primordial soup where life began on earth was hot and not cold, as many scientists believe.
As the coronavirus disease (COVID-19) pandemic continues to spread and wreak havoc globally, another health threat emerged in China. The country has reported its first confirmed case of the rare H10N3 bird flu in a patient admitted to the hospital in April 2021 in Zhenjiang, China.
Pfizer Inc. announced today that the European Commission has granted conditional marketing authorization for BOSULIF (bosutinib) in the European Union for the treatment of adult patients with chronic phase, accelerated phase and blast phase Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, and Intellikine, Inc., a leader in the development of small molecule drugs targeting the PI3K/mTOR pathway, today announced an agreement under which Infinity obtained global development and commercialization rights to Intellikine's portfolio of inhibitors of the delta and gamma isoforms of phosphoinositide-3-kinase.
› Verified 5 days ago
Diana Jaime, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 942 Lake Baldwin Ln, Orlando, FL 32814 Phone: 407-895-8059 | |
Richard Luke Elloway, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 7751 Kingspointe Pkwy Ste 114, Orlando, FL 32819 Phone: 407-581-9672 Fax: 407-581-9673 | |
Dr. Cristina P Garcia, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2863 S Delaney Ave, Orlando, FL 32806 Phone: 407-843-1620 Fax: 407-843-5243 | |
Dr. Sandra Ivelisse Alvarez, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 13800 Veterans Way, Hero Clinic 1f, Orlando, FL 32827 Phone: 407-631-1000 | |
Tayyaba Nadir Tariq, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6320 Old Winter Garden Rd, Orlando, FL 32835 Phone: 407-290-0555 Fax: 407-295-0028 | |
Dr. Christopher Patrick Carroll, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9400 Turkey Lake Rd, Orlando, FL 32819 Phone: 321-843-5500 Fax: 321-843-5550 | |
Dr. Keith Allan Campbell, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11221 John Wycliffe Blvd, Orlando, FL 32832 Phone: 407-852-3880 Fax: 407-852-3881 |